Findings suggest targeting neuro-immune pathway could lead to strategies for managing diabetes, obesity or some types of ...

This paper to be published in Science reveals a surprising new role for immune cells in regulating blood sugar. Key Findings: ...

The liver and pancreas are the main actors in glucose metabolism, but not the only ones. Muscles, adipose tissue and the brain play different roles. However, the prize for the best new actor in ...

Recent research has highlighted the importance of glucagon-like peptide-1 (GLP-1) and its analogs in this context, as they play a significant role in beta-cell function and survival. Various ...

The study proposes the immune system as a major regulator of blood sugar. The functions of hormones like insulin and glucagon ...

During fasting or exercise, immune cells (red) migrate to the pancreas and stimulate glucagon-producing cells (orange) to regulate blood sugar, with cell nuclei shown in blue.

Israeli and American researchers uncovered the role of a specific enzyme in managing blood sugar levels in a study that opens up new therapeutic possibilities for people with type 2 diabetes. Type 2 ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

New study shows that the gene G6PC2 plays an important role in regulating glucagon, a hormone that raises blood sugar levels.

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...

Immune cells unexpectedly regulate blood sugar levels, offering new insights for managing diabetes, obesity, and cancer.